219 related articles for article (PubMed ID: 31115276)
21. Defective Levothyroxine Response in a Patient with Dyshormonogenic Congenital Hypothyroidism Caused by a Concurrent Pathogenic Variant in Thyroid Hormone Receptor-β.
Lauffer P; Bikker H; Garrelfs MR; Hillebrand JJG; de Sonnaville MCS; Zwaveling-Soonawala N; van Trotsenburg ASP
Thyroid; 2021 Nov; 31(11):1757-1762. PubMed ID: 34382419
[No Abstract] [Full Text] [Related]
22. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect.
Kosugi S; Bhayana S; Dean HJ
J Clin Endocrinol Metab; 1999 Sep; 84(9):3248-53. PubMed ID: 10487695
[TBL] [Abstract][Full Text] [Related]
23. Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program.
Maruo Y; Takahashi H; Soeda I; Nishikura N; Matsui K; Ota Y; Mimura Y; Mori A; Sato H; Takeuchi Y
J Clin Endocrinol Metab; 2008 Nov; 93(11):4261-7. PubMed ID: 18765513
[TBL] [Abstract][Full Text] [Related]
24. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Bizhanova A; Kopp P
Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
[TBL] [Abstract][Full Text] [Related]
25. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site.
Pohlenz J; Rosenthal IM; Weiss RE; Jhiang SM; Burant C; Refetoff S
J Clin Invest; 1998 Mar; 101(5):1028-35. PubMed ID: 9486973
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
27. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
28. An extremely high dietary iodide supply forestalls severe hypothyroidism in Na
Ferrandino G; Kaspari RR; Reyna-Neyra A; Boutagy NE; Sinusas AJ; Carrasco N
Sci Rep; 2017 Jul; 7(1):5329. PubMed ID: 28706256
[TBL] [Abstract][Full Text] [Related]
29. Implications of Na
Martín M; Geysels RC; Peyret V; Bernal Barquero CE; Masini-Repiso AM; Nicola JP
J Endocr Soc; 2019 Jan; 3(1):222-234. PubMed ID: 30620007
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of iodide transport defect: do we need to measure the saliva/serum radioactive iodide ratio to diagnose iodide transport defect?
Fukata S; Hishinuma A; Nakatake N; Tajiri J
Thyroid; 2010 Dec; 20(12):1419-21. PubMed ID: 21054210
[TBL] [Abstract][Full Text] [Related]
31. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients.
Kosugi S; Inoue S; Matsuda A; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3373-6. PubMed ID: 9745458
[TBL] [Abstract][Full Text] [Related]
32. Genetic Evaluation of Congenital Hypothyroidism with Gland
Shin JH; Kim HY; Kim YM; Lee H; Bae MH; Park KH; Lee SM; Kwak MJ
Ann Clin Lab Sci; 2021 Jan; 51(1):73-81. PubMed ID: 33653783
[TBL] [Abstract][Full Text] [Related]
33. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
[TBL] [Abstract][Full Text] [Related]
34. Mutation screening of the sodium iodide symporter gene in a cohort of 105 China patients with congenital hypothyroidism.
Fu C; Chen S; Chen R; Fan X; Luo J; Li C; Qian J
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):828-32. PubMed ID: 25465605
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
36. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
37. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
De La Vieja A; Dohan O; Levy O; Carrasco N
Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
[TBL] [Abstract][Full Text] [Related]
39. Targeted Next-Generation Sequencing for Congenital Hypothyroidism With Positive Neonatal TSH Screening.
Yamaguchi T; Nakamura A; Nakayama K; Hishimura N; Morikawa S; Ishizu K; Tajima T
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459320
[TBL] [Abstract][Full Text] [Related]
40. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
